.jpeg/jcr:content.jpeg)
Vaccines
Science in Vaccines
Beyfortus® Real-World Effectiveness: Meta-Analysis
Systematic review shows Beyfortus® reduces RSV hospitalizations by 83% and ICU admissions by 81% in real-world infant immunization programs.
Expert consensus on the burden of RSV disease and the utility of nirsevimab for disease prevention and
protection of infants
Nirsevimab: Revolutionizing RSV Prevention for All Infants
Join us for an insightful RSV Prevention event featuring expert presentations on the latest advances in respiratory syncytial virus prevention strategies for all infants. Gain valuable insights through four comprehensive video presentations, into systematic reviews of effectiveness data, healthcare system implementation approaches, global prevention strategies, and the significant impact of RSV prevention on reducing disease burden in pediatric populations.
Key insights from WSPID 2025 are here!
Discover the latest breakthroughs in pediatric infectious diseases, focusing on Pertussis, Polio and Hib protection.
![[Post-Webinar] Shielding Golden Years: The Power of Flu Vaccines for Older Adults](/.imaging/webp/sanofi-templates/w384-4-3/dam/campus-sanofi-my/science/events/past-event/the-power-of-flu-vaccines-for-older-adults/thumbnail-400-x-300.png/jcr:content/thumbnail-400%20x%20300.png)
[Post-Webinar] Shielding Golden Years: The Power of Flu Vaccines for Older Adults
Experts across Southeast Asia shared insights on influenza in older adults, highlighting disease burden, regional epidemiology, and the crucial role of vaccination for this high-risk group.
![[Post-Webinar] Vaccination in Pregnancy: An Essential Component of Antenatal Care](/.imaging/webp/sanofi-templates/w384-4-3/dam/campus-sanofi-my/science/events/past-event/vip2025/vip_thumbnail.png/jcr:content/vip_thumbnail.png)
Please log in or register to continue reading.
Patient-Video
Request-form
